Revenues for the six months ended June 30 were up 40% year-on-year at £27.9mln, with the figure set to more than double to £60-£65mln for the full-year.
Full interview: Circassia Pharmaceuticals' commercial development 'accelerating significantly'
Quick facts: Circassia Group PLC
Price: 24.4 GBX
Market Cap: £91.97 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Circassia Group PLC named herein, including the promotion by the Company of Circassia Group PLC in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE